Our immune system works all the time to protect us from harmful bacteria, viruses, and injuries. It is a complex system made up of many different parts that work together to keep the body safe.
One important part of this system is called the complement system. This system is a group of proteins in the blood that helps find and destroy harmful invaders. It also helps clean up damaged cells and supports healing.
For more than 100 years, scientists believed they understood how the complement system works. It was thought to be mainly activated by infections or injury.
However, a new study from Mass General Brigham has changed this understanding in an important way. The research, published in the journal Nature, shows that a protein called granzyme K, or GZMK, can activate the complement system in a harmful way.
Instead of helping the body, GZMK can cause the immune system to attack the body’s own tissues. This leads to long-term inflammation and damage. Inflammation is the body’s natural response to injury or infection, but when it becomes chronic, it can harm healthy tissues and lead to disease.
The study was led by Dr. Carlos Donado at Brigham and Women’s Hospital, under the guidance of Dr. Michael Brenner. The researchers focused on a type of immune cell called CD8+ T cells. These cells usually help fight infections, but they also produce GZMK.
The scientists noticed that these cells are very active in areas of the body affected by inflammatory diseases. These include conditions such as rheumatoid arthritis and psoriasis. In these diseases, the immune system mistakenly attacks the body’s own tissues, causing pain, swelling, and damage.
Other research has also found these GZMK-producing cells in a wide range of conditions. These include heart disease, brain diseases, cancer, and even normal aging. Because of this, scientists began to suspect that GZMK might play a key role in many different types of inflammation.
To better understand this, the researchers carried out several experiments. They studied the structure of the GZMK protein and compared it with other known proteins.
They also tested whether GZMK could activate the complement system. In addition, they examined tissue samples from patients with rheumatoid arthritis and used animal models to observe how GZMK affects the body.
The results showed that GZMK can activate the entire complement system. This leads to a chain reaction that increases inflammation, attracts more immune cells, and causes damage to tissues. This process can continue over time, leading to chronic disease.
To confirm their findings, the researchers studied animals that did not have the GZMK protein. They used two models: one that mimics rheumatoid arthritis and another that mimics a skin condition similar to psoriasis.
The results were clear. Animals without GZMK had much less inflammation. They also showed fewer signs of disease and less activation of the complement system.
This suggests that GZMK plays a central role in driving harmful inflammation. Because of this, it could be an important target for new treatments.
Current treatments for autoimmune diseases often work by suppressing the entire immune system. While this can reduce symptoms, it also makes patients more vulnerable to infections. This is a major challenge in treating these conditions.
The new findings offer a different approach. Instead of shutting down the whole immune system, future treatments could target GZMK specifically. This could block harmful inflammation while still allowing the body to fight infections normally.
Dr. Erin Theisen, one of the lead researchers, explained that targeting GZMK could have wide benefits because inflammation is involved in many different diseases. Dr. Brenner also said that the team is now working on developing drugs that can block GZMK safely.
In the future, researchers plan to study how GZMK works in more detail across different diseases. They also aim to test new treatments in humans to see if they can reduce inflammation without causing serious side effects.
This discovery is important because it changes how scientists understand the immune system. It shows that the body’s own defense system can sometimes turn against itself in unexpected ways.
If new treatments based on this research are successful, they could improve the lives of millions of people who suffer from chronic inflammatory diseases. It may also lead to safer and more precise ways to treat these conditions.
Overall, this study highlights the importance of continuing research into the immune system. By learning more about how it works, scientists can find better ways to prevent and treat disease, helping people live healthier lives.
If you care about inflammation, please read studies about turmeric: nature’s golden answer to inflammation, and what to eat to reduce chronic Inflammation.
For more health information, please see recent studies about how a plant-based diet could help ease inflammation ,and Vitamin D deficiency linked to increased inflammation.
Copyright © 2026 Knowridge Science Report. All rights reserved.
